Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.33 trillion and total revenue of $115.7 billion.
Market Cap
1.33T
Revenue
115.7B
Profits
-39.65B
PE Ratio
n/a
Profit Margin
-34.27%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 133.96B | 2.52% | 913,903 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.30B | 1.02% | 352,427 | 15.53B |
| 3 | ARGX | argenx SE | 62.99B | 0.92% | 265,767 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 46.34B | 1.98% | 1,223,840 | - |
| 5 | ONC | BeOne Medicines AG | 42.12B | 2.20% | 332,112 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 34.46B | 0.81% | 1,404,858 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.74B | 2.29% | 1,056,160 | 4.80B |
| 8 | INSM | Insmed Incorporated | 28.12B | 0.36% | 686,615 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.99B | 3.09% | 3,171,838 | 7.53M |
| 10 | MRNA | Moderna, Inc. | 25.43B | -1.18% | 2,544,002 | 2.23B |
| 11 | INCY | Incyte Corporation | 25.13B | 0.40% | 502,121 | 5.82B |
| 12 | BNTX | BioNTech SE | 23.34B | 1.45% | 685,105 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.45B | 0.43% | 1,760,675 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 16.54B | 2.57% | 310,141 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 16.47B | 1.35% | 278,572 | 1.20B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.16B | 3.47% | 2,099,993 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.16B | 1.49% | 778,470 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 13.10B | 1.59% | 1,091,959 | 3.41B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.82B | 1.21% | 490,730 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.36B | -1.36% | 575,494 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | -0.73% | 174,627 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.90B | 1.82% | 1,272,839 | 1.66B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 11.30B | -0.27% | 250,140 | 776.57M |
| 24 | TECH | Bio-Techne Corporation | 11.27B | -0.08% | 2,109,251 | 1.22B |
| 25 | CYTK | Cytokinetics, Incorporated | 10.60B | 0.54% | 1,097,055 | 67.67M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 10.38B | -1.21% | 189,537 | 7.46M |
| 27 | SMMT | Summit Therapeutics Inc. | 10.29B | 0.94% | 3,473,895 | - |
| 28 | ABVX | ABIVAX Société Anonyme | 10.27B | -1.02% | 372,185 | 5.67M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 10.21B | -0.56% | 243,429 | 281.99M |
| 30 | APGE | Apogee Therapeutics, Inc. | 10.15B | - | 738,319 | - |
| 31 | KYMR | Kymera Therapeutics, Inc. | 10.14B | 0.40% | 335,734 | 105.00M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.89B | 1.55% | 1,512,574 | 874.09M |
| 33 | KRYS | Krystal Biotech, Inc. | 9.87B | -0.70% | 83,117 | 440.48M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.49B | 2.90% | 653,885 | - |
| 35 | IMVT | Immunovant, Inc. | 9.05B | 0.21% | 1,005,937 | - |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.02% | 2,383,505 | 42.16M |
| 37 | PCVX | Vaxcyte, Inc. | 8.91B | -0.53% | 342,023 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.11B | -3.41% | 3,751,652 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.99B | 0.51% | 286,762 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 7.48B | 0.26% | 420,083 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.08B | 1.28% | 504,578 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.73B | -1.60% | 337,006 | 6.23M |
| 43 | SRRK | Scholar Rock Holding Corporation | 6.60B | 4.19% | 898,904 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 6.51B | -0.92% | 661,222 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 6.49B | 0.11% | 278,598 | 618.07M |
| 46 | DNTH | Dianthus Therapeutics, Inc. | 6.46B | 0.49% | 318,144 | 1.90M |
| 47 | BLTE | Belite Bio, Inc | 6.45B | 0.48% | 65,324 | - |
| 48 | ERAS | Erasca, Inc. | 6.41B | 0.33% | 1,154,574 | - |
| 49 | DFTX | Definium Therapeutics, Inc. | 6.18B | 1.59% | 1,472,247 | - |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 6.10B | 0.95% | 603,923 | 7.50M |
| 51 | PTCT | PTC Therapeutics, Inc. | 6.06B | -0.34% | 448,938 | 1.01B |
| 52 | TVTX | Travere Therapeutics, Inc. | 6.01B | 0.41% | 582,729 | 591.33M |
| 53 | CAI | Caris Life Sciences, Inc. | 5.89B | -3.56% | 2,340,921 | 989.61M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | -1.41% | 130,640 | 290.54M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 5.18B | 3.62% | 1,308,417 | 1.14B |
| 56 | CRSP | CRISPR Therapeutics AG | 5.13B | -2.17% | 998,083 | 13.39M |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.88B | 6.05% | 494,965 | 148.00K |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.87B | -0.34% | 822,628 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.76B | -0.52% | 539,527 | - |
| 60 | MANE | Veradermics, Incorporated | 4.62B | 2.26% | 273,079 | - |
| 61 | CELC | Celcuity Inc. | 4.59B | 1.48% | 338,181 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.49B | -0.97% | 1,339,543 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.40B | 0.78% | 421,260 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.25B | -0.36% | 1,500,531 | 53.81M |
| 65 | LEGN | Legend Biotech Corporation | 4.22B | 5.67% | 2,463,802 | 1.27B |
| 66 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.45% | 33,211 | 803.79M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.90B | -0.51% | 788,212 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 3.90B | 0.08% | 537,827 | 3.60M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.81B | -0.61% | 391,863 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.79B | 0.71% | 594,799 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.64B | 3.31% | 407,643 | 234.13M |
| 72 | ABCL | AbCellera Biologics Inc. | 3.61B | -0.45% | 6,592,658 | 66.17M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 3.83% | 1,225,399 | 463.98M |
| 74 | QURE | uniQure N.V. | 3.30B | -0.81% | 330,541 | 18.67M |
| 75 | CLDX | Celldex Therapeutics, Inc. | 3.28B | -0.33% | 558,341 | 158.00K |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 3.25B | 0.99% | 556,892 | 7.12M |
| 77 | ALMS | Alumis Inc. | 3.22B | -2.47% | 435,089 | 7.40M |
| 78 | IOVA | Iovance Biotherapeutics, Inc. | 3.19B | -0.85% | 8,515,105 | 324.97M |
| 79 | MBX | MBX Biosciences, Inc. | 3.18B | -3.30% | 426,810 | - |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | 0.36% | 437,906 | 606.33M |
| 81 | IMNM | Immunome, Inc. | 3.11B | -0.11% | 474,005 | 4.02M |
| 82 | IRON | Disc Medicine, Inc. | 3.10B | 0.74% | 241,224 | - |
| 83 | ZLAB | Zai Lab Limited | 2.86B | -0.51% | 1,162,031 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -1.10% | 450,089 | 36.77M |
| 85 | ATAI | AtaiBeckley Inc. | 2.70B | 0.69% | 9,153,859 | 4.47M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.69B | 2.11% | 851,803 | - |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.69B | 2.77% | 1,368,282 | 71.13M |
| 88 | BEAM | Beam Therapeutics Inc. | 2.66B | -1.88% | 842,219 | 156.04M |
| 89 | SLS | SELLAS Life Sciences Group, Inc. | 2.64B | 0.38% | 4,251,684 | - |
| 90 | NKTR | Nektar Therapeutics | 2.56B | 3.01% | 366,748 | 54.59M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.51B | -2.37% | 978,300 | 717.00M |
| 92 | KOD | Kodiak Sciences Inc. | 2.50B | -2.59% | 405,665 | - |
| 93 | PHVS | Pharvaris N.V. | 2.49B | 0.51% | 423,663 | - |
| 94 | COAG | Hemab Therapeutics Holdings, Inc. | 2.46B | -1.74% | 122,701 | - |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.43B | 4.04% | 3,412,673 | 52.06M |
| 96 | NUVB | Nuvation Bio Inc. | 2.42B | 6.56% | 5,160,008 | 169.90M |
| 97 | PGEN | Precigen, Inc. | 2.40B | 2.29% | 2,831,421 | 85.72M |
| 98 | URGN | UroGen Pharma Ltd. | 2.40B | -0.28% | 533,673 | 188.73M |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | 2.69% | 758,792 | - |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.36B | 1.76% | 121,117 | 20.00M |
| 101 | VERA | Vera Therapeutics, Inc. | 2.32B | 1.74% | 704,788 | - |
| 102 | KLRA | Kailera Therapeutics, Inc. | 2.32B | -3.46% | 1,123,555 | - |
| 103 | VCEL | Vericel Corporation | 2.27B | 1.86% | 312,489 | 306.30M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.94% | 252,147 | 959.90M |
| 105 | MESO | Mesoblast Limited | 2.22B | -2.00% | 155,731 | 65.38M |
| 106 | PVLA | Palvella Therapeutics, Inc. | 2.20B | -0.37% | 101,753 | - |
| 107 | ADMA | ADMA Biologics, Inc. | 2.12B | 1.55% | 791,582 | 512.28M |
| 108 | STOK | Stoke Therapeutics, Inc. | 2.09B | 0.78% | 445,957 | 27.59M |
| 109 | GENB | Generate Biomedicines, Inc. | 2.09B | 3.70% | 467,634 | 26.48M |
| 110 | BHVN | Biohaven Ltd. | 2.07B | -5.05% | 1,180,991 | - |
| 111 | NBTX | Nanobiotix S.A. | 2.07B | -2.46% | 140,104 | 38.27M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 2.06B | 3.61% | 445,648 | 1.00M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 2.32% | 535,656 | 98.34M |
| 114 | SEPN | Septerna, Inc. | 2.05B | -0.86% | 190,317 | 98.88M |
| 115 | GHRS | GH Research PLC | 2.04B | -0.67% | 176,473 | - |
| 116 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | - | 472,395 | 311.51M |
| 117 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | 0.48% | 998,241 | 5.49M |
| 118 | KARD | Kardigan, Inc. | 1.96B | 1.92% | 163,408 | - |
| 119 | DMRA | Damora Therapeutics, Inc. | 1.94B | 1.25% | 262,900 | - |
| 120 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.03% | 438,649 | - |
| 121 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -0.33% | 757,457 | 1.97B |
| 122 | XNCR | Xencor, Inc. | 1.86B | 8.43% | 885,943 | 104.97M |
| 123 | IMCR | Immunocore Holdings plc | 1.86B | 3.17% | 389,168 | 430.78M |
| 124 | ZYME | Zymeworks Inc. | 1.86B | 3.60% | 378,499 | 37.13M |
| 125 | LKFT | Lakefront Biotherapeutics NV | 1.84B | 1.13% | 238,299 | 1.13B |
| 126 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.61% | 629,995 | 252.25M |
| 127 | AVLN | Avalyn Pharma Inc. | 1.76B | 3.58% | 136,381 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.74B | -1.29% | 142,263 | 232.39M |
| 129 | BRVE | Braveheart Bio, Inc. | 1.72B | -3.29% | 145,944 | - |
| 130 | FTRE | Fortrea Holdings Inc. | 1.69B | -1.93% | 405,738 | 2.68B |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.64B | -0.48% | 203,220 | - |
| 132 | AAPG | Ascentage Pharma Group International | 1.64B | -1.04% | 6,481 | 82.08M |
| 133 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -2.89% | 13,435,831 | 54.86M |
| 134 | NTLA | Intellia Therapeutics, Inc. | 1.62B | -4.43% | 2,379,026 | 59.51M |
| 135 | TRAX | First Tracks Biotherapeutics, Inc. | 1.62B | 3.81% | 435,993 | - |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.62B | 4.04% | 443,042 | 20.00M |
| 137 | VIR | Vir Biotechnology, Inc. | 1.60B | 0.85% | 788,997 | 303.23M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.57B | 5.54% | 390,983 | - |
| 139 | TYRA | Tyra Biosciences, Inc. | 1.55B | -0.84% | 239,094 | - |
| 140 | SLBT | SL Science Holding Limited | 1.54B | -2.17% | 15,988 | 3.27M |
| 141 | INVA | Innoviva, Inc. | 1.53B | 1.22% | 251,379 | 440.00M |
| 142 | ABSI | Absci Corporation | 1.51B | -5.09% | 1,995,863 | 1.56M |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.49B | 1.32% | 1,102,068 | 208.78M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 4.14% | 213,131 | - |
| 145 | JBIO | Jade Biosciences, Inc. | 1.48B | -0.90% | 427,429 | - |
| 146 | REPL | Replimune Group, Inc. | 1.46B | 5.88% | 1,371,986 | - |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.45B | 4.48% | 599,130 | - |
| 148 | VOR | Vor Biopharma Inc. | 1.40B | 2.52% | 575,707 | - |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.39B | - | 592,596 | - |
| 150 | INBX | Inhibrx Biosciences, Inc. | 1.38B | 1.71% | 224,528 | 1.30M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.38B | 0.04% | 80,672 | 10.06M |
| 152 | SVRA | Savara Inc. | 1.36B | - | 988,506 | - |
| 153 | ANRO | Alto Neuroscience, Inc. | 1.35B | 2.08% | 337,530 | - |
| 154 | MGTX | MeiraGTx Holdings plc | 1.34B | 1.38% | 403,873 | 397.50M |
| 155 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 0.05% | 405,777 | - |
| 156 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 0.78% | 321,583 | - |
| 157 | MNKD | MannKind Corporation | 1.31B | 4.10% | 2,993,503 | 393.63M |
| 158 | NVAX | Novavax, Inc. | 1.30B | -1.98% | 1,167,167 | 413.80M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30B | -1.04% | 758,765 | 28.73M |
| 160 | SPTX | Seaport Therapeutics, Inc. | 1.28B | -1.72% | 75,140 | - |
| 161 | APMD | Apnimed, Inc. | 1.27B | -2.15% | 309,170 | 120.15M |
| 162 | LTGO | Latigo Biotherapeutics, Inc. | 1.26B | 2.90% | 182,982 | - |
| 163 | OMER | Omeros Corporation | 1.25B | -0.78% | 833,914 | 38.42M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -0.87% | 354,318 | - |
| 165 | IMTX | Immatics N.V. | 1.24B | -2.11% | 515,645 | 43.00M |
| 166 | IVA | Inventiva S.A. | 1.11B | -1.28% | 691,200 | 7.94M |
| 167 | KURA | Kura Oncology, Inc. | 1.10B | 9.22% | 3,220,781 | 77.23M |
| 168 | SANA | Sana Biotechnology, Inc. | 1.10B | -0.54% | 1,593,955 | - |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 3.42% | 2,334,930 | 41.47M |
| 170 | AVTX | Avalo Therapeutics, Inc. | 1.07B | -0.20% | 833,433 | 59.00K |
| 171 | ODTX | Odyssey Therapeutics, Inc. | 1.04B | 4.07% | 147,498 | 99.00K |
| 172 | WVE | Wave Life Sciences Ltd. | 1.04B | 3.34% | 1,798,210 | 65.37M |
| 173 | JANX | Janux Therapeutics, Inc. | 1.02B | 2.95% | 323,379 | 24.00M |
| 174 | CLYM | Climb Bio, Inc. | 1.00B | 0.23% | 727,390 | - |
| 175 | ATTO | Attovia Therapeutics, Inc. | 998.27M | 2.16% | 126,989 | 1.35M |
| 176 | ANNX | Annexon, Inc. | 997.19M | 2.53% | 1,002,545 | - |
| 177 | GERN | Geron Corporation | 979.77M | -0.33% | 2,122,887 | 204.56M |
| 178 | ARDX | Ardelyx, Inc. | 975.57M | -3.57% | 2,953,906 | 450.89M |
| 179 | SLDB | Solid Biosciences Inc. | 969.32M | -0.66% | 341,310 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 952.64M | 2.23% | 1,043,482 | 181.72M |
| 181 | DSGN | Design Therapeutics, Inc. | 950.62M | 0.60% | 491,971 | - |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 934.47M | -0.84% | 651,044 | - |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 924.41M | 6.08% | 1,508,717 | 8.22M |
| 184 | CADL | Candel Therapeutics, Inc. | 913.63M | -1.81% | 533,085 | - |
| 185 | ANL | Adlai Nortye Ltd. | 911.55M | 6.11% | 139,718 | 18.06M |
| 186 | FTH | Faeth Therapeutics, Inc. | 900.02M | 6.29% | 285,117 | - |
| 187 | TBPH | Theravance Biopharma, Inc. | 880.02M | 0.18% | 73,048 | 104.31M |
| 188 | DBVT | DBV Technologies S.A. | 871.61M | -0.75% | 146,841 | 5.04M |
| 189 | SGP | SpyGlass Pharma, Inc. | 868.98M | 0.78% | 39,009 | - |
| 190 | AURA | Aura Biosciences, Inc. | 846.23M | 6.25% | 463,495 | - |
| 191 | SLN | Silence Therapeutics plc | 844.14M | -2.30% | 1,365,468 | 615.00K |
| 192 | IMMX | Immix Biopharma, Inc. | 843.45M | 3.97% | 992,044 | - |
| 193 | PHAR | Pharming Group N.V. | 839.53M | 0.93% | 20,076 | 366.48M |
| 194 | OBX | Obsidian Therapeutics, Inc. | 836.20M | 10.07% | 100,350 | - |
| 195 | OCS | Oculis Holding AG | 813.94M | 0.34% | 141,343 | 1.45M |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 809.59M | 2.10% | 171,684 | 276.79M |
| 197 | MNPR | Monopar Therapeutics Inc. | 801.63M | 2.52% | 106,204 | - |
| 198 | FDMT | 4D Molecular Therapeutics, Inc. | 799.38M | -0.52% | 1,172,028 | 92.01M |
| 199 | DRUG | Bright Minds Biosciences Inc. | 769.03M | 5.56% | 105,126 | - |
| 200 | ACHV | Achieve Life Sciences, Inc. | 761.99M | -1.27% | 740,308 | - |
| 201 | STTK | Shattuck Labs, Inc. | 741.68M | - | 325,178 | 1.00M |
| 202 | CTMX | CytomX Therapeutics, Inc. | 736.50M | -2.03% | 1,830,530 | 18.30M |
| 203 | GYRE | Gyre Therapeutics, Inc. | 732.69M | 1.47% | 34,664 | 109.82M |
| 204 | PHAT | Phathom Pharmaceuticals, Inc. | 732.35M | -0.65% | 678,693 | 239.66M |
| 205 | RGNX | REGENXBIO Inc. | 729.45M | -2.47% | 423,350 | 174.48M |
| 206 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 719.16M | -0.77% | 223,642 | - |
| 207 | HELP | Cybin Inc. | 715.92M | -0.17% | 722,603 | - |
| 208 | NGNE | Neurogene Inc. | 714.51M | -2.66% | 48,175 | 925.00K |
| 209 | TECX | Tectonic Therapeutic, Inc. | 713.94M | 7.89% | 371,219 | - |
| 210 | CBIO | Crescent Biopharma, Inc. | 711.57M | -4.89% | 112,094 | 11.88M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 708.26M | -1.44% | 3,315,522 | 4.64M |
| 212 | ZVRA | Zevra Therapeutics, Inc. | 688.26M | 0.52% | 621,129 | 136.07M |
| 213 | VSTM | Verastem, Inc. | 679.68M | 4.53% | 2,019,926 | 87.53M |
| 214 | NVCT | Nuvectis Pharma, Inc. | 677.04M | 8.91% | 163,462 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 673.71M | - | 23,819 | - |
| 216 | SGMT | Sagimet Biosciences Inc. | 658.26M | 1.53% | 735,521 | - |
| 217 | ASMB | Assembly Biosciences, Inc. | 651.54M | 6.63% | 390,495 | 74.85M |
| 218 | VALN | Valneva SE | 647.09M | -1.63% | 55,114 | 163.30M |
| 219 | CRMD | CorMedix Inc. | 631.35M | 5.61% | 1,279,313 | 462.25M |
| 220 | SPRY | ARS Pharmaceuticals, Inc. | 629.00M | 1.36% | 1,488,371 | 116.93M |
| 221 | MDXG | MiMedx Group, Inc. | 622.40M | 1.91% | 849,904 | 355.17M |
| 222 | EIKN | Eikon Therapeutics, Inc. | 621.27M | 9.55% | 564,964 | - |
| 223 | AUTL | Autolus Therapeutics plc | 608.18M | 0.22% | 2,856,671 | 117.39M |
| 224 | ARVN | Arvinas, Inc. | 607.44M | 0.98% | 324,886 | 316.70M |
| 225 | PRLD | Prelude Therapeutics Incorporated | 594.28M | 2.49% | 169,554 | 22.42M |
| 226 | ALT | Altimmune, Inc. | 581.61M | -0.33% | 1,603,651 | 31.00K |
| 227 | ARTV | Artiva Biotherapeutics, Inc. | 574.95M | 0.17% | 186,054 | 251.00K |
| 228 | OABI | OmniAb, Inc. | 572.84M | 3.14% | 2,838,708 | 38.46M |
| 229 | OVID | Ovid Therapeutics Inc. | 560.50M | -0.69% | 1,497,518 | 1.58M |
| 230 | ZURA | Zura Bio Limited | 554.37M | 1.85% | 739,116 | - |
| 231 | CTNM | Contineum Therapeutics, Inc. | 547.76M | 0.21% | 264,903 | - |
| 232 | MPLT | MapLight Therapeutics, Inc. | 546.79M | 4.85% | 323,075 | - |
| 233 | PRME | Prime Medicine, Inc. | 544.39M | -3.47% | 897,421 | 4.07M |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 525.67M | -5.03% | 682,342 | - |
| 235 | EVMN | Evommune, Inc. | 520.43M | 0.63% | 244,480 | 10.00M |
| 236 | CCCC | C4 Therapeutics, Inc. | 518.55M | -1.17% | 2,333,145 | 35.04M |
| 237 | RLMD | Relmada Therapeutics, Inc. | 514.68M | 1.15% | 466,615 | - |
| 238 | SCTX | Scribe Therapeutics Inc. | 514.43M | 28.69% | 430,163 | 36.28M |
| 239 | ENTX | Entera Bio Ltd. | 502.11M | - | 173,133 | 42.00K |
| 240 | BLSM | BlossomHill Therapeutics, Inc. | 494.90M | -1.40% | 243,163 | - |
| 241 | CABA | Cabaletta Bio, Inc. | 490.83M | 0.17% | 5,863,028 | - |
| 242 | RZLT | Rezolute, Inc. | 485.25M | -0.75% | 473,846 | - |
| 243 | PBYI | Puma Biotechnology, Inc. | 480.58M | 5.56% | 155,412 | 231.24M |
| 244 | EYPT | EyePoint, Inc. | 472.87M | 12.63% | 13,984,304 | 2.79M |
| 245 | OCGN | Ocugen, Inc. | 456.10M | -2.18% | 2,095,673 | 4.58M |
| 246 | QTTB | Q32 Bio Inc. | 453.98M | -4.39% | 209,496 | 53.74M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.39M | -0.44% | 323,145 | - |
| 248 | PRTA | Prothena Corporation plc | 446.63M | -2.03% | 133,815 | 54.53M |
| 249 | EDIT | Editas Medicine, Inc. | 440.77M | 1.06% | 1,933,758 | 47.01M |
| 250 | DNA | Ginkgo Bioworks Holdings, Inc. | 439.73M | -5.64% | 857,020 | 132.42M |
| 251 | BNTC | Benitec Biopharma Inc. | 436.99M | -2.68% | 183,049 | - |
| 252 | IKT | Inhibikase Therapeutics, Inc. | 436.07M | 0.21% | 239,729 | 1.00 |
| 253 | LRMR | Larimar Therapeutics, Inc. | 431.10M | -4.40% | 581,067 | - |
| 254 | CMPX | Compass Therapeutics, Inc. | 430.41M | 3.46% | 2,237,428 | 850.00K |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 421.07M | 0.57% | 67,797 | - |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 418.70M | 0.93% | 84,302 | 59.22M |
| 257 | PROK | ProKidney Corp. | 417.21M | -1.43% | 794,498 | 818.00K |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 414.93M | -2.67% | 252,642 | 15.85M |
| 259 | CAPR | Capricor Therapeutics, Inc. | 411.04M | -5.10% | 7,454,963 | 11.13M |
| 260 | LXEO | Lexeo Therapeutics, Inc. | 410.21M | 0.40% | 359,746 | - |
| 261 | FHTX | Foghorn Therapeutics Inc. | 402.63M | 0.59% | 103,086 | 36.74M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 389.55M | 4.25% | 94,983 | 65.26M |
| 263 | VTVT | vTv Therapeutics Inc. | 387.03M | -0.51% | 57,965 | 36.84M |
| 264 | UPB | Upstream Bio, Inc. | 374.09M | -4.34% | 276,477 | 3.16M |
| 265 | LYEL | Lyell Immunopharma, Inc. | 373.83M | 12.58% | 223,074 | 27.00K |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 370.65M | 0.36% | 6,932 | 64.24M |
| 267 | STRO | Sutro Biopharma, Inc. | 367.11M | -0.63% | 459,824 | 45.70M |
| 268 | RCKT | Rocket Pharmaceuticals, Inc. | 365.00M | -2.21% | 732,982 | - |
| 269 | ABEO | Abeona Therapeutics Inc. | 359.12M | 5.72% | 876,827 | 25.52M |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 354.02M | -0.83% | 45,739 | - |
| 271 | GALT | Galectin Therapeutics Inc. | 353.98M | - | 247,905 | - |
| 272 | IPSC | Century Therapeutics, Inc. | 353.10M | - | 267,510 | 109.16M |
| 273 | PALI | Palisade Bio, Inc. | 352.90M | -5.81% | 1,820,967 | 500.00K |
| 274 | SABS | SAB Biotherapeutics, Inc. | 345.29M | 0.66% | 288,115 | 114.70K |
| 275 | OBIO | Orchestra BioMed Holdings, Inc. | 342.60M | 20.76% | 1,954,804 | 31.98M |
| 276 | AGEN | Agenus Inc. | 336.75M | 4.62% | 651,679 | 132.69M |
| 277 | VCRE | Vicore Pharma Holding AB (publ) | 327.24M | -2.62% | 393 | 370.61K |
| 278 | IMRX | Immuneering Corporation | 327.05M | -3.16% | 414,391 | - |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 326.50M | 2.66% | 668,652 | 215.72M |
| 280 | IFRX | InflaRx N.V. | 319.79M | 4.83% | 448,873 | -11.54K |
| 281 | FATE | Fate Therapeutics, Inc. | 309.74M | -1.34% | 734,780 | 6.49M |
| 282 | CAMP | Camp4 Therapeutics Corporation | 305.61M | -2.60% | 82,539 | 4.22M |
| 283 | IRD | Opus Genetics, Inc. | 304.58M | 0.30% | 549,187 | 9.86M |
| 284 | NMRA | Neumora Therapeutics, Inc. | 302.51M | 5.92% | 512,188 | - |
| 285 | PRQR | ProQR Therapeutics N.V. | 299.18M | 9.84% | 1,251,462 | 21.05M |
| 286 | AVXL | Anavex Life Sciences Corp. | 295.62M | -0.62% | 280,991 | - |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 295.27M | 0.78% | 2,161,526 | 80.00M |
| 288 | ELDN | Eledon Pharmaceuticals, Inc. | 295.27M | 1.40% | 408,826 | - |
| 289 | TTRX | Turn Therapeutics Inc. | 292.97M | -0.76% | 10,590 | - |
| 290 | ALXO | ALX Oncology Holdings Inc. | 287.62M | 5.58% | 674,637 | - |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 281.37M | 1.31% | 100,822 | 1.48M |
| 292 | YDES | YD Bio Limited | 281.28M | 18.69% | 68,225 | 510.36K |
| 293 | BCYC | Bicycle Therapeutics plc | 279.27M | -0.25% | 69,412 | 61.21M |
| 294 | SRZN | Surrozen, Inc. | 276.56M | -1.05% | 108,051 | 11.51M |
| 295 | ADAG | Adagene Inc. | 275.29M | 7.05% | 270,172 | 9.29M |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 272.22M | 2.91% | 108,794 | 7.15M |
| 297 | LCTX | Lineage Cell Therapeutics, Inc. | 270.61M | 0.94% | 914,990 | 13.08M |
| 298 | SION | Sionna Therapeutics, Inc. | 267.66M | 0.17% | 1,529,688 | - |
| 299 | VOGX | Vogenx, Inc. | 265.83M | 21.27% | 745,592 | - |
| 300 | CNXU | Conexeu Sciences Inc. | 264.91M | 1.23% | 329,452 | - |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 264.82M | -2.41% | 31,319 | 18.47M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 262.49M | -0.55% | 67,912 | 4.69M |
| 303 | MGNX | MacroGenics, Inc. | 261.81M | 1.23% | 290,613 | 175.14M |
| 304 | ZNTL | Zentalis Pharmaceuticals, Inc. | 260.89M | -1.75% | 867,979 | 26.87M |
| 305 | IVVD | Invivyd, Inc. | 255.88M | 17.23% | 6,781,969 | 58.37M |
| 306 | GLSI | Greenwich LifeSciences, Inc. | 255.55M | 0.17% | 65,078 | - |
| 307 | ACIU | AC Immune SA | 255.03M | 1.38% | 63,761 | 21.67M |
| 308 | PYXS | Pyxis Oncology, Inc. | 251.06M | -0.33% | 250,443 | 11.04M |
| 309 | ALEC | Alector, Inc. | 244.53M | 6.83% | 4,599,573 | 13.86M |
| 310 | NAGE | Niagen Bioscience, Inc. | 239.07M | -0.82% | 356,823 | 129.08M |
| 311 | TARA | Protara Therapeutics, Inc. | 235.20M | - | 202,550 | - |
| 312 | ARCT | Arcturus Therapeutics Holdings Inc. | 234.49M | 1.35% | 326,401 | 29.37M |
| 313 | CLLS | Cellectis S.A. | 229.89M | -1.73% | 23,199 | 63.82M |
| 314 | IMUX | Immunic, Inc. | 225.20M | 2.96% | 203,945 | - |
| 315 | DTIL | Precision BioSciences, Inc. | 224.95M | 10.14% | 214,330 | 45.06M |
| 316 | CGEN | Compugen Ltd. | 224.50M | 0.85% | 85,683 | 74.00M |
| 317 | ANTX | AN2 Therapeutics, Inc. | 222.27M | 2.79% | 124,640 | - |
| 318 | NBP | NovaBridge Biosciences | 219.73M | -1.55% | 171,066 | - |
| 319 | RNA | Atrium Therapeutics, Inc. | 219.12M | -1.16% | 79,235 | 35.84M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 217.56M | 0.20% | 140,883 | 29.10M |
| 321 | NERV | Minerva Neurosciences, Inc. | 216.06M | 2.38% | 66,305 | - |
| 322 | KROS | Keros Therapeutics, Inc. | 209.18M | 0.67% | 168,227 | 15.01M |
| 323 | VYGR | Voyager Therapeutics, Inc. | 205.80M | 3.41% | 367,204 | 34.46M |
| 324 | MSLE | Satellos Bioscience Inc. | 204.25M | -1.21% | 3,973 | - |
| 325 | CHRS | Coherus Oncology, Inc. | 203.17M | 14.35% | 2,901,359 | 50.94M |
| 326 | PEPG | PepGen Inc. | 202.58M | -3.78% | 547,017 | - |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 201.40M | 4.70% | 210,471 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 197.38M | 3.83% | 250,766 | 2.00M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 196.51M | -3.15% | 244,172 | - |
| 330 | IPHA | Innate Pharma S.A. | 196.48M | -8.63% | 37,918 | 10.57M |
| 331 | KRRO | Korro Bio, Inc. | 192.17M | -0.68% | 46,382 | 2.38M |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 187.73M | 1.75% | 174,174 | 80.62M |
| 333 | ACOG | Alpha Cognition Inc. | 186.82M | -2.94% | 120,455 | 15.26M |
| 334 | NGEN | NervGen Pharma Corp. | 180.90M | 1.19% | 331,865 | - |
| 335 | MDWD | MediWound Ltd. | 175.58M | 1.57% | 41,331 | 11.86M |
| 336 | NKTX | Nkarta, Inc. | 173.33M | -0.41% | 156,692 | - |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 170.67M | 2.46% | 23,577 | 5.54M |
| 338 | OKUR | OnKure Therapeutics, Inc. | 170.08M | 2.19% | 65,170 | - |
| 339 | CRBU | Caribou Biosciences, Inc. | 167.78M | -0.32% | 428,173 | 10.04M |
| 340 | KZIA | Kazia Therapeutics Limited | 165.69M | 6.93% | 131,441 | 1.27M |
| 341 | CDXS | Codexis, Inc. | 164.81M | -5.35% | 637,745 | 77.68M |
| 342 | HUMA | Humacyte, Inc. | 162.40M | 4.28% | 8,759,510 | 2.12M |
| 343 | CNTN | Canton Strategic Holdings, Inc. | 160.56M | -0.49% | 556,170 | 1.50M |
| 344 | MOLN | Molecular Partners AG | 157.47M | 0.94% | 531 | 856.30K |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 156.83M | 1.08% | 600,131 | - |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 155.86M | -0.71% | 2,085,417 | 1.34M |
| 347 | CNTB | Connect Biopharma Holdings Limited | 153.03M | -2.41% | 264,649 | 2.95M |
| 348 | SPRB | Spruce Biosciences, Inc. | 152.61M | 0.34% | 65,656 | 697.00K |
| 349 | LENZ | LENZ Therapeutics, Inc. | 152.07M | 1.04% | 336,434 | 21.48M |
| 350 | MIST | Milestone Pharmaceuticals Inc. | 150.77M | -2.73% | 1,122,690 | 2.34M |
| 351 | EQ | Equillium, Inc. | 148.58M | -5.24% | 622,019 | 4.39M |
| 352 | TLSA | Tiziana Life Sciences Ltd | 147.41M | -0.87% | 1,488,468 | - |
| 353 | MENS | Jyong Biotech Ltd. | 146.24M | -1.99% | 24,363 | - |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 142.90M | 17.09% | 273,822 | 39.99K |
| 355 | NRXP | NRx Pharmaceuticals, Inc. | 142.08M | -1.17% | 743,404 | 3.39M |
| 356 | HURA | TuHURA Biosciences, Inc. | 139.78M | -3.73% | 250,452 | - |
| 357 | AARD | Aardvark Therapeutics, Inc. | 133.72M | -9.35% | 52,159 | - |
| 358 | PMN | ProMIS Neurosciences, Inc. | 132.18M | 0.55% | 13,822 | - |
| 359 | OTLK | Outlook Therapeutics, Inc. | 128.49M | 2.22% | 37,987,420 | -1.16M |
| 360 | CBUS | Cibus, Inc. | 126.49M | -0.90% | 112,096 | 4.35M |
| 361 | INO | Inovio Pharmaceuticals, Inc. | 123.56M | 3.91% | 4,270,021 | 65.34K |
| 362 | VANI | Vivani Medical, Inc. | 119.87M | 2.96% | 124,389 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 118.35M | 0.49% | 312,204 | 70.00M |
| 364 | YARW | Yarrow Bioscience, Inc. | 118.33M | 2.08% | 14,184 | - |
| 365 | ANIX | Anixa Biosciences, Inc. | 117.04M | -1.43% | 103,637 | - |
| 366 | ENGN | enGene Therapeutics Inc. | 115.22M | 1.18% | 603,651 | - |
| 367 | COYA | Coya Therapeutics, Inc. | 115.17M | 5.14% | 86,680 | 8.02M |
| 368 | GNLX | Genelux Corporation | 115.02M | -4.07% | 253,659 | 8.00K |
| 369 | GUTS | Fractyl Health, Inc. | 114.10M | 8.61% | 1,480,378 | 3.00K |
| 370 | SEER | Seer, Inc. | 112.13M | -0.25% | 204,492 | 14.22M |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 111.81M | 3.03% | 2,579,245 | 4.88M |
| 372 | NAUT | Nautilus Biotechnology, Inc. | 108.69M | -3.00% | 388,496 | 190.00K |
| 373 | ONCY | Oncolytics Biotech Inc. | 108.24M | 3.18% | 675,121 | - |
| 374 | CUE | Cue Biopharma, Inc. | 107.11M | -7.74% | 244,450 | 37.66M |
| 375 | PLYX | Polaryx Therapeutics, Inc. | 105.67M | 0.95% | 73,488 | - |
| 376 | INDP | Indaptus Therapeutics, Inc. | 105.56M | -6.78% | 277,296 | - |
| 377 | ACET | Adicet Bio, Inc. | 98.39M | 4.58% | 94,465 | - |
| 378 | BMEA | Biomea Fusion, Inc. | 97.85M | - | 584,864 | - |
| 379 | TENX | Tenax Therapeutics, Inc. | 97.38M | -0.58% | 7,466,058 | - |
| 380 | PYPD | PolyPid Ltd. | 95.26M | -1.68% | 93,454 | - |
| 381 | KLRS | Kalaris Therapeutics, Inc. | 94.74M | 0.51% | 15,122 | - |
| 382 | FBIO | Fortress Biotech, Inc. | 94.72M | 0.71% | 449,550 | 68.47M |
| 383 | CGTX | Cognition Therapeutics, Inc. | 93.97M | -3.12% | 344,964 | - |
| 384 | ALDX | Aldeyra Therapeutics, Inc. | 93.81M | -0.32% | 599,158 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 92.23M | 2.45% | 19,084 | 43.30M |
| 386 | RLYB | Rallybio Corporation | 90.33M | 0.06% | 8,611 | 646.00K |
| 387 | ICCC | ImmuCell Corporation | 88.55M | 0.52% | 7,422 | 30.68M |
| 388 | GANX | Gain Therapeutics, Inc. | 88.16M | -0.98% | 321,469 | - |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 87.85M | - | 311,303 | - |
| 390 | ATRA | Atara Biotherapeutics, Inc. | 86.83M | 3.47% | 17,626 | 6.19M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 84.85M | 0.36% | 177,092 | - |
| 392 | VRCA | Verrica Pharmaceuticals Inc. | 83.73M | -0.32% | 38,817 | 30.32M |
| 393 | ELTX | Elicio Therapeutics, Inc. | 80.69M | 1.66% | 272,700 | - |
| 394 | NRXS | NeurAxis, Inc. | 78.86M | - | 27,350 | 5.32M |
| 395 | OKYO | OKYO Pharma Limited | 78.72M | -1.32% | 45,222 | - |
| 396 | ATHE | Alterity Therapeutics Limited | 77.16M | -0.22% | 9,118 | 4.43M |
| 397 | ANVS | Annovis Bio, Inc. | 76.15M | 2.87% | 348,542 | - |
| 398 | LONA | LeonaBio, Inc. | 75.15M | 3.76% | 521,632 | - |
| 399 | TELO | Telomir Pharmaceuticals, Inc. | 73.93M | 1.42% | 23,747 | - |
| 400 | CSBR | Champions Oncology, Inc. | 71.83M | 2.78% | 10,512 | 59.43M |
| 401 | IBIO | iBio, Inc. | 71.54M | -0.69% | 2,393,070 | 300.00K |
| 402 | PLRX | Pliant Therapeutics, Inc. | 71.21M | 4.55% | 1,247,430 | - |
| 403 | ELOX | Eloxx Pharmaceuticals, Inc. | 71.00M | -4.76% | 36,052 | - |
| 404 | DWTX | Dogwood Therapeutics, Inc. | 70.96M | 2.43% | 25,987 | - |
| 405 | GOSS | Gossamer Bio, Inc. | 70.10M | 2.43% | 5,712,752 | 53.29M |
| 406 | XBIT | XBiotech Inc. | 69.82M | -0.87% | 43,746 | - |
| 407 | SPRO | Spero Therapeutics, Inc. | 69.59M | 0.42% | 401,785 | 47.00M |
| 408 | CING | Cingulate Inc. | 69.23M | -1.34% | 90,874 | - |
| 409 | SER | Serina Therapeutics, Inc. | 68.58M | -5.26% | 48,359 | 130.00K |
| 410 | CRDF | Cardiff Oncology, Inc. | 67.68M | -3.79% | 550,440 | 508.00K |
| 411 | RNTX | Rein Therapeutics Inc. | 66.91M | -7.02% | 479,506 | - |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 66.40M | -0.40% | 97,145 | - |
| 413 | MNOV | MediciNova, Inc. | 66.13M | 1.78% | 43,879 | 920.48K |
| 414 | BOLD | Boundless Bio, Inc. | 65.40M | 1.59% | 115,240 | - |
| 415 | IMA | ImageneBio, Inc. | 65.21M | 2.96% | 6,526 | 800.00K |
| 416 | OSTX | OS Therapies Incorporated | 64.58M | -1.36% | 203,860 | - |
| 417 | XLO | Xilio Therapeutics, Inc. | 62.58M | 0.21% | 10,643 | 64.09M |
| 418 | HYFT | MindWalk Holdings Corp. | 62.26M | -0.38% | 164,920 | 11.43M |
| 419 | INKT | MiNK Therapeutics, Inc. | 59.58M | 6.60% | 7,846 | - |
| 420 | EXOZ | eXoZymes, Inc. | 59.22M | 7.79% | 822 | -700.00 |
| 421 | INMB | INmune Bio Inc. | 58.84M | -0.47% | 207,902 | 50.00K |
| 422 | HRTX | Heron Therapeutics, Inc. | 56.96M | -6.25% | 3,856,190 | 151.18M |
| 423 | BSEM | BioStem Technologies, Inc. | 56.40M | 5.33% | 33,397 | 34.59M |
| 424 | TCRX | TScan Therapeutics, Inc. | 55.84M | 5.15% | 150,200 | 7.11M |
| 425 | EDSA | Edesa Biotech, Inc. | 55.49M | 1.95% | 43,843 | - |
| 426 | IMMP | Immutep Limited | 55.41M | 2.61% | 82,663 | 5.28M |
| 427 | RNXT | RenovoRx, Inc. | 52.80M | -2.50% | 465,753 | 1.98M |
| 428 | APLM | Apollomics, Inc. | 52.71M | 1.91% | 17,981 | 8.84M |
| 429 | IBO | Impact BioMedical Inc. | 50.68M | -1.55% | 24,711 | 35.00K |
| 430 | ATYR | aTyr Pharma, Inc. | 50.27M | -1.23% | 575,440 | 190.00K |
| 431 | TIL | Instil Bio, Inc. | 49.64M | -0.54% | 2,173 | - |
| 432 | MREO | Mereo BioPharma Group plc | 49.18M | 0.10% | 751,913 | 500.00K |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 46.28M | 0.41% | 62,701 | 13.56M |
| 434 | CNTX | Context Therapeutics Inc. | 45.79M | -6.02% | 3,145,824 | - |
| 435 | VRXA | Veraxa Biotech AG | 45.39M | -3.23% | 95,118 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.49M | -2.08% | 100,077 | - |
| 437 | VERU | Veru Inc. | 44.16M | -1.52% | 91,396 | 16.89M |
| 438 | ALPS | Alps Group Inc | 44.10M | -17.24% | 105,882 | 3.74M |
| 439 | KPTI | Karyopharm Therapeutics Inc. | 43.78M | 6.63% | 931,787 | 146.62M |
| 440 | MCRB | Seres Therapeutics, Inc. | 43.74M | -2.44% | 53,072 | 1.88M |
| 441 | HYPD | Hyperion DeFi, Inc. | 42.42M | -3.87% | 180,396 | 1.40M |
| 442 | FLNA | Filana Therapeutics, Inc. | 41.75M | -2.90% | 362,734 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 41.65M | 1.44% | 96,251 | 31.52M |
| 444 | NTRB | Nutriband Inc. | 41.45M | 5.57% | 4,420 | 1.80M |
| 445 | CRVO | CervoMed Inc. | 39.01M | -1.15% | 293,600 | 331.30K |
| 446 | RADX | Radiopharm Theranostics Limited | 37.01M | 1.69% | 37,195 | 10.86M |
| 447 | ESLA | Estrella Immunopharma, Inc. | 35.01M | 7.01% | 24,104 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 33.49M | 1.43% | 57,860 | 35.09M |
| 449 | QNCX | Quince Therapeutics, Inc. | 32.76M | -1.82% | 25,555 | - |
| 450 | LTRN | Lantern Pharma Inc. | 32.60M | -1.92% | 53,948 | - |
| 451 | NNVC | NanoViricides, Inc. | 30.53M | -1.47% | 234,613 | - |
| 452 | LITS | Lite Strategy, Inc. | 30.34M | 1.32% | 64,039 | - |
| 453 | NXTC | NextCure, Inc. | 30.12M | -14.66% | 244,073 | - |
| 454 | BCTX | BriaCell Therapeutics Corp. | 29.48M | 2.06% | 66,004 | - |
| 455 | BYSI | BeyondSpring Inc. | 29.20M | -0.21% | 133,489 | 1.88M |
| 456 | IGC | IGC Pharma, Inc. | 29.12M | 0.61% | 476,078 | 1.11M |
| 457 | KYNB | Kyntra Bio, Inc. | 28.63M | 3.82% | 11,976 | 4.62M |
| 458 | GRDX | GridAI Technologies Corp. | 28.61M | 2.28% | 155,593 | - |
| 459 | CVM | CEL-SCI Corporation | 28.14M | 3.87% | 211,785 | - |
| 460 | DYAI | Dyadic International, Inc. | 27.89M | -1.90% | 159,536 | 3.80M |
| 461 | GNTA | Genenta Science S.p.A. | 26.89M | -9.52% | 39,211 | - |
| 462 | ENLV | Enlivex Ltd. | 26.75M | -3.16% | 116,108 | - |
| 463 | TVGN | Tevogen Inc. | 26.58M | -4.26% | 7,926 | - |
| 464 | EVAX | Evaxion A/S | 26.19M | 0.32% | 10,320 | 7.53M |
| 465 | BRNS | Barinthus Biotherapeutics plc | 26.04M | 7.42% | 73,642 | 14.97M |
| 466 | ATOS | Atossa Therapeutics, Inc. | 25.55M | -8.24% | 54,627 | - |
| 467 | LGVN | Longeveron Inc. | 25.52M | -2.40% | 485,332 | 1.19M |
| 468 | ACTU | Actuate Therapeutics, Inc. | 24.88M | 5.05% | 312,119 | - |
| 469 | JSPR | Jasper Therapeutics, Inc. | 24.19M | -13.51% | 1,586,413 | - |
| 470 | QNTM | Quantum BioPharma Ltd. | 23.99M | -11.96% | 274,011 | - |
| 471 | CALC | CalciMedica, Inc. | 22.85M | 1.03% | 95,115 | - |
| 472 | CELU | Celularity Inc. | 22.14M | 9.91% | 71,521 | 26.55M |
| 473 | ABVC | ABVC BioPharma, Inc. | 21.89M | 1.91% | 75,893 | 797.92K |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 21.56M | 3.64% | 235,504 | -13.27K |
| 475 | CNSY | Cerenome, Inc. | 21.34M | -3.13% | 78,457 | 4.20M |
| 476 | COCP | Cocrystal Pharma, Inc. | 20.90M | -0.46% | 63,320 | 330.00K |
| 477 | ALLR | Allarity Therapeutics, Inc. | 20.85M | -2.22% | 30,400 | 345.00K |
| 478 | CLRB | Cellectar Biosciences, Inc. | 20.62M | 0.78% | 29,158 | - |
| 479 | LEXX | Lexaria Bioscience Corp. | 19.83M | 16.28% | 24,054 | 194.00K |
| 480 | HOWL | Werewolf Therapeutics, Inc. | 19.75M | 0.20% | 82,270 | 21.00M |
| 481 | MRKR | Marker Therapeutics, Inc. | 19.42M | 0.43% | 43,878 | 2.69M |
| 482 | PLRZ | Polyrizon Ltd. | 19.30M | -6.10% | 282,495 | - |
| 483 | CYCN | Cyclerion Therapeutics, Inc. | 18.48M | -0.50% | 10,406 | 1.90M |
| 484 | PTN | Palatin Technologies, Inc. | 17.74M | 5.53% | 21,985 | 12.88M |
| 485 | NCEL | NewcelX Ltd. | 17.66M | 0.61% | 7,059 | - |
| 486 | PLUR | Pluri Inc. | 17.37M | 0.63% | 10,043 | 1.08M |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 17.36M | -0.54% | 75,091 | - |
| 488 | LPCN | Lipocine Inc. | 16.90M | - | 25,482 | 1.57M |
| 489 | PBM | Psyence Biomedical Ltd. | 16.78M | 21.88% | 777,509 | - |
| 490 | TPST | Tempest Therapeutics, Inc. | 16.78M | -7.09% | 238,944 | - |
| 491 | KTTA | Pasithea Therapeutics Corp. | 16.47M | 3.14% | 91,668 | - |
| 492 | KALA | KALA BIO, Inc. | 16.36M | -3.31% | 20,651 | - |
| 493 | HIND | Vyome Holdings, Inc. | 15.93M | - | 3,020 | 129.73K |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 15.70M | 1.76% | 329,163 | 7.11M |
| 495 | AKTX | Akari Therapeutics, Plc | 14.96M | 2.19% | 95,321 | - |
| 496 | PASG | Passage Bio, Inc. | 14.90M | 1.98% | 6,777 | - |
| 497 | MLEC | Moolec Science SA | 14.88M | -16.56% | 15,684 | 7.83M |
| 498 | ICU | SeaStar Medical Holding Corporation | 14.54M | 1.54% | 26,282 | 1.71M |
| 499 | NRSN | NeuroSense Therapeutics Ltd. | 14.23M | -10.88% | 280,082 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 14.17M | 4.58% | 7,249 | - |